CONTROLLED EXPRESSION OF NEOGLYCANS IN ANIMAL CELLS
动物细胞中新聚糖的受控表达
基本信息
- 批准号:3305402
- 负责人:
- 金额:$ 19.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-08-01 至 1995-07-31
- 项目状态:已结题
- 来源:
- 关键词:CHO cells SDS polyacrylamide gel electrophoresis affinity chromatography carbohydrate structure gene expression glycolipids glycoprotein biosynthesis glycoprotein structure glycoproteins glycosylation glycosyltransferase high performance liquid chromatography human genetic material tag lipid structure membrane proteins oligosaccharides radiotracer tissue /cell culture transfection transferrin receptor
项目摘要
Animal cells synthesize a complex pattern of oligosaccharides on their
glycoconjugates. In a single cell, glycoproteins may demonstrate site-
specific glycosylation, controlled microheterogeneity of the
oligosaccharide at each site, and differential glycosylation relative to
the oligosaccharides found on glycosphingolipids. Since the configuration
of oligosaccharides at cell surfaces is presumed to provide individuality
of cellular function and behavior, these glycosylation reactions must be
exquisitely controlled; however, our understanding of the many elements
involved in regulating animal cell glycosylation is severely limited. The
objective of this research is to understand more about the precise role of
glycosyltransferases in the regulation of glycoconjugate biosynthesis in
animal cells. This will be accomplished by monitoring the structural
changes in glycoconjugates (neoglycans) as a result of a single genetic
event, namely, the introduction of a "new" glycosyltransferase gene into a
"wild type" background. Chinese hamster ovary (CHO) cells will be used as
"naive" recipients for the stable expression of cloned cDNAs encoding a
murine (alpha1,3)galactosyltransferase and three human fucosyltransferases:
the blood group H (alpha1,2)fucosyltransferase, the Lewis blood group (Fuc
to GlcNAc-alpha1,3/4)fucosyltransferase, and the (Fuc to
GlcNAcalpha1,3)galactosyltransferase. The structural features of
metabolically radiolabeled glycoconjugates synthesized by these cell lines
will be determined and compared to parental-cell oligosaccharides. To
determine if specific glycoproteins in these cell lines are preferentially
glycosylated with neoglycans, metabolically radiolabeled glycoproteins will
be resolved by SDS-PAGE gels and subjected to partial structural
characterization of their neoglycans. The CHO cell transferrin receptor
and Lysosome Associated Membrane Proteins (LAMPs), known to exhibit
different oligosaccharide side chains, will be used as "reporter
glycoproteins" to determine if and to what degree their N-linked
oligosaccharides are modified by the newly expressed glycosyltransferase.
The degree to which there is a direct relationship between transcript
levels, specific enzyme activities, and the relative amounts of neoglycan
synthesized by transfected cells will be determined by analyses of the
metabolically radiolabeled glycoconjugates in cell lines constructed so
that the dosages of glycosyltransferase genes are increased. These studies
will provide important new information on the precise role of
glycosyltransferases in terminal glycosylation reactions, as well as,
contribute to defining factors that orchestrate the complex oligosaccharide
patterns expressed by animal cells.
动物细胞合成一种复杂的寡糖,
糖缀合物 在单个细胞中,糖蛋白可以显示位点-
特异性糖基化,
每个位点的寡糖,以及相对于
在鞘糖脂上发现的寡糖。 由于配置
据推测,细胞表面的低聚糖
细胞功能和行为的,这些糖基化反应必须
然而,我们对许多元素的理解
参与调节动物细胞糖基化的基因受到严重限制。 的
这项研究的目的是了解更多关于确切的作用,
糖基转移酶在调节糖缀合物生物合成中的作用
动物细胞 这将通过监测结构来实现
糖缀合物(新聚糖)的变化是由于单一的遗传
事件,即,将“新的”糖基转移酶基因引入到
“野生型”背景。 中国仓鼠卵巢(CHO)细胞将用作
“幼稚”受体用于稳定表达克隆的编码
鼠(α 1,3)半乳糖基转移酶和三种人岩藻糖基转移酶:
血型H(α 1,2)岩藻糖基转移酶、刘易斯血型(Fuc
至GlcNAc-α 1,3/4)岩藻糖基转移酶,以及(Fuc至
GlcNA α 1,3)半乳糖基转移酶。 的结构特点
由这些细胞系合成的代谢放射性标记的糖缀合物
将被测定并与亲本细胞寡糖进行比较。 到
确定这些细胞系中的特定糖蛋白是否优先
用新聚糖糖基化,代谢放射性标记的糖蛋白将
通过SDS-PAGE凝胶分离,并进行部分结构分析。
其新聚糖的表征。 CHO细胞转铁蛋白受体
和溶酶体相关膜蛋白(LAMP),已知表现出
不同的寡糖侧链,将被用作“报告基因
糖蛋白”来确定它们的N-连接
寡糖被新表达的糖基转移酶修饰。
成绩单与学生成绩之间的直接关系
水平、特定酶活性和新聚糖的相对量
将通过分析转染细胞合成的蛋白质来确定。
代谢放射性标记的糖缀合物在细胞系中的构建,
糖基转移酶基因的剂量增加。 这些研究
将提供重要的新信息,
在末端糖基化反应中的糖基转移酶,以及,
有助于定义协调复杂寡糖的因素
动物细胞表达的模式。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID F SMITH其他文献
DAVID F SMITH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID F SMITH', 18)}}的其他基金
BIOLUMINESCENT ASSAY FOR QUANTIFYING PCR PRODUCTS
用于定量 PCR 产物的生物发光测定
- 批准号:
2004759 - 财政年份:1996
- 资助金额:
$ 19.38万 - 项目类别:
CRYPTOSPORIDOSIS--A BIOLUMINESCENT CRYPTOSPORIDIUM ASSAY
隐孢子虫病——生物发光隐孢子虫检测
- 批准号:
2075775 - 财政年份:1995
- 资助金额:
$ 19.38万 - 项目类别:
BIOLUMINESCENT DETECTION OF MYCOBACTERIUM TUBERCULOSIS
结核分枝杆菌的生物发光检测
- 批准号:
2074152 - 财政年份:1995
- 资助金额:
$ 19.38万 - 项目类别:
GLYCOSYLATION STATUS ASSAYS FOR DIAGNOSTIC TUMOR MARKERS
诊断肿瘤标志物的糖基化状态测定
- 批准号:
3493251 - 财政年份:1992
- 资助金额:
$ 19.38万 - 项目类别:
CONTROLLED EXPRESSION OF NEOGLYCANS IN ANIMAL CELLS
动物细胞中新聚糖的受控表达
- 批准号:
3305400 - 财政年份:1991
- 资助金额:
$ 19.38万 - 项目类别:
CONTROLLED EXPRESSION OF NEOGLYCANS IN ANIMAL CELLS
动物细胞中新聚糖的受控表达
- 批准号:
3305403 - 财政年份:1991
- 资助金额:
$ 19.38万 - 项目类别:
GLYCOSYLTRANSFERASE LUMINESCENCE ASSAY: A NEW TECHNOLOGY
糖基转移酶发光测定:新技术
- 批准号:
2181763 - 财政年份:1989
- 资助金额:
$ 19.38万 - 项目类别:
LUMINESCENCE DETECTION REAGENTS FOR FOOD PATHOGENS
食物病原体发光检测试剂
- 批准号:
3506108 - 财政年份:1989
- 资助金额:
$ 19.38万 - 项目类别: